HK1218622A1 - 含有改性瓜尔胶的药物软明胶胶囊剂型 - Google Patents

含有改性瓜尔胶的药物软明胶胶囊剂型 Download PDF

Info

Publication number
HK1218622A1
HK1218622A1 HK16106609.2A HK16106609A HK1218622A1 HK 1218622 A1 HK1218622 A1 HK 1218622A1 HK 16106609 A HK16106609 A HK 16106609A HK 1218622 A1 HK1218622 A1 HK 1218622A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
guar gum
Prior art date
Application number
HK16106609.2A
Other languages
English (en)
Chinese (zh)
Inventor
Brendan Muldoon
Ryan Gerald LOUGHLIN
Gerarde SWEENEY
Emma Karen BOYD
Original Assignee
Warner Chilcott Company, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Company, Llc filed Critical Warner Chilcott Company, Llc
Publication of HK1218622A1 publication Critical patent/HK1218622A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16106609.2A 2013-03-15 2014-03-14 含有改性瓜尔胶的药物软明胶胶囊剂型 HK1218622A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15
US61/794,906 2013-03-15
PCT/US2014/027145 WO2014152269A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Publications (1)

Publication Number Publication Date
HK1218622A1 true HK1218622A1 (zh) 2017-03-03

Family

ID=50588879

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106609.2A HK1218622A1 (zh) 2013-03-15 2014-03-14 含有改性瓜尔胶的药物软明胶胶囊剂型

Country Status (14)

Country Link
US (3) US9795569B2 (https=)
EP (2) EP3187170A1 (https=)
JP (3) JP6335270B2 (https=)
KR (1) KR20150131070A (https=)
CN (2) CN105307634B (https=)
AU (2) AU2014239994B2 (https=)
BR (1) BR112015022946A8 (https=)
CA (1) CA2906633C (https=)
ES (1) ES2619121T3 (https=)
HK (1) HK1218622A1 (https=)
IL (1) IL241377B (https=)
MX (2) MX364440B (https=)
RU (1) RU2676480C2 (https=)
WO (1) WO2014152269A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906633C (en) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum
ES2787220T3 (es) 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
CN116916895A (zh) * 2020-11-13 2023-10-20 辉瑞公司 他拉唑帕尼软明胶胶囊剂型
CA3201467A1 (en) * 2020-11-13 2022-05-19 Pfizer Inc. Talazoparib soft gelatin capsule dosage form
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药(广东)有限公司 镇咳清肺软胶囊及其制备工艺

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
IN188719B (https=) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
US20070066837A1 (en) 2003-02-18 2007-03-22 Ahmed Kamal Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
CN1906206A (zh) 2004-01-15 2007-01-31 沃纳奇尔科特公司 雌二醇的二-甾族前体药物
CA2553816A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
CA2612380C (en) 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
EP1910401A2 (en) 2005-07-12 2008-04-16 Warner Chilcott Company, Inc. 3-ester prodrugs of ethynylestradiol
CA2610481A1 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
WO2007056424A2 (en) 2005-11-07 2007-05-18 Penwest Pharmaceuticals, Co. Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
JP2009526040A (ja) 2006-02-10 2009-07-16 エル・ジー ハウスホールド アンド ヘルスケア リミティッド 同時溶解及びゲル化錠剤型の口腔衛生組成物
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
EP2114380A1 (en) 2007-01-25 2009-11-11 Panacea Biotec Ltd. Modified release pharmaceutical composition and a process of making the same
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
CN101971130A (zh) 2008-03-26 2011-02-09 十字科技股份有限公司 光学指向装置及具有该光学指向装置的便携式电子装置
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
CA2906633C (en) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Also Published As

Publication number Publication date
ES2619121T3 (es) 2017-06-23
JP6704430B2 (ja) 2020-06-03
KR20150131070A (ko) 2015-11-24
US10744096B2 (en) 2020-08-18
JP2018140998A (ja) 2018-09-13
US20180036252A1 (en) 2018-02-08
CN105307634A (zh) 2016-02-03
MX2019004554A (es) 2019-08-05
AU2014239994A1 (en) 2015-10-08
IL241377A0 (en) 2015-11-30
EP2950781B1 (en) 2016-12-21
WO2014152269A1 (en) 2014-09-25
US20150044285A1 (en) 2015-02-12
CA2906633A1 (en) 2014-09-25
MX2015012057A (es) 2016-05-05
AU2014239994B2 (en) 2019-01-24
JP2020147569A (ja) 2020-09-17
US9820946B2 (en) 2017-11-21
EP3187170A1 (en) 2017-07-05
JP2016513684A (ja) 2016-05-16
EP2950781A1 (en) 2015-12-09
IL241377B (en) 2019-08-29
BR112015022946A2 (pt) 2017-07-18
CN105307634B (zh) 2020-03-10
US9795569B2 (en) 2017-10-24
CA2906633C (en) 2021-11-30
NZ712280A (en) 2021-01-29
MX364440B (es) 2019-04-26
AU2019200116A1 (en) 2019-01-31
BR112015022946A8 (pt) 2022-11-29
CN111374959A (zh) 2020-07-07
JP6335270B2 (ja) 2018-05-30
RU2015137612A (ru) 2017-04-24
US20140271838A1 (en) 2014-09-18
RU2676480C2 (ru) 2018-12-29

Similar Documents

Publication Publication Date Title
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
MX2015011163A (es) Capsula entericas blandas que no contienen gelatina.
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
AU2013317899A8 (en) Biodegradable microcapsules containing filling material
MX2015008069A (es) Conjunto de envasado para dispositivos de administracion de farmacos.
EP3384891A4 (en) MEDICAMENT CARTET, DRUG DELIVERY AND MEDICAMENT PACKAGING DEVICE
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
HK1220113A1 (zh) 药物软明胶胶囊剂型
EP3318217A4 (en) PROTHESIS PACKAGING, PROSTHESIS AND PROSTHESIS WITH PACKAGING
HK1249442A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
IN2013MU03370A (https=)
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
HK1249441A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
HK1249440A1 (zh) 具有改善的储存稳定性的药物组合物及其制备方法
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
IN2014MU00043A (https=)
WO2013144976A3 (en) Chewable soft gelatin capsule dosage form of mucolytic agents
GB2600367B (en) Shape memory alloy based drug delivery device
IN2013CH04473A (https=)
IN2013MU02015A (https=)
UY35324A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
吕茜颖 A Report on The Translation of Economic Reviews in Financial Times
王娟 The Contrastive Multimodal Study between Chinese and Western Movie Posters